Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues

Journal of Cellular Biochemistry

Volumn 105, Issue 3, 2008, Pages 703-711

  Alvarez, Sergio E ^a   Seguin, Leonardo R ^a   Villarreal, Rodrigo S ^a   Nahmias, Clara ^b   Ciuffo, Gladys M ^a  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^b INSTITUT COCHIN   (France)

Author keywords

Ang II; AT2 receptors; Development; SHP 1 activation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1;

ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; FETUS (ANATOMY); GENE SEQUENCE; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; FEMALE; FETUS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION;

RATTUS;

EID: 54849420903     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21866     Document Type: Article

References (42)

1. Ali MS, Schiefer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB. 1997. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem 272:12373-12379.
2. Alvarez SE, Fuentes LB, Ciuffo GM. 2003. Angiotensin II mediates Tyrdephosphorylation in rat fetal kidney membranes. Mol Cel Biochem 254:137-143.
3. Arce ME, Sanchez S, Seltzer A, Ciuffo GM. 2001. Autoradiographic localization of angiotensin II receptors in developing rat cerebellum and brainstem. Regul Pept 99:53-60.
4. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. 1997. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 325:449-454.
5. Bousquet C, Delesque N, Lopez F, Saint-Laurent N, Esteve JP, Bedecs K, Buscail L, Vaysse N, Susini C. 1998. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem 273:7099-7106.
6. Bursell L, Woods A, James CG, Pala D, Leask A, Beier F. 2007. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther 9:R105-R116.
7. Ciuffo GM, Alvarez SE, Fuentes LB. 1998. Angiotensin II receptors induce tyrosine dephosphorylation in rat fetal membranes. Regul Pept 74:129-135.
8. 2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc Res 49:863-871.
9. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger TH. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472.
10. Deshayes F, Nahmias C. 2005. Angiotensin receptors: A new role in cancer? Trends Endocrinol Metab 16:293-299.
11. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
12. Elbaz N, Bedecs K, Masson M, Sutren M, Strosberg AD, Nahmias C. 2000. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Mol Endocrinol 14:795-804.
13. 2-mediated ITIM-independent activation of SHP-1. Proc Natl Acad Sci 99:12049-12054.
14. Feng YH, Zhou L, Sun Y, Douglas JG. 2005. Functional diversity of AT2 receptor orthologues in closely related species. Kidney Int 67:1731-1738.
15. Frank C, Burkhardt C, Imhof D, Ringel J, Zschörnig O, Wieligmann K, Zacharias M, Böhmer F. 2004. Effective dephosphorylation of Src substrates by SHP-1. J Biol Chem 279:11375-11383.
16. Gallinat S, Busche S, Raizada MK, Summers C. 2000. The angiotensin II type 2 receptor: An enigma with multiple variations. Am J Physiol Endocrinol Metab 278:E357-E374.
17. Gendron L, Payet MD, Gallo-Payet N. 2003. The Angiotensin type 2 receptor of angiotensin II and neuronal differentiation: From observations to mechanisms. J Mol Endocrinol 31:359-372.
18. Godeny MD, Sayeski PP. 2006. Ang II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn regulated ERK1/2 activation in the cytoplasm and PKCzeta-controlled ERK1/2 activity within the nucleus. Am J Physiol Cell Physiol 291:C1297-C1307.
19. Harder KW, Owen P, Wong LKH, Aebersold R, Clark-Lewis I, Jirik FR. 1994. Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase β (HPTPβ) using synthetic phosphopeptides. Biochem J 298:395-401.
20. 1 receptor: Novel insights into mechanisms and pathophysiology. Clin Sci 112:417-428.
21. Horiuchi M, Lehtonen J, Daviet L. 1999. Signaling mechanism of the AT2 angiotensin II receptor: Crosstalk between AT1 and AT2 receptors in cell growth. Trends Endocrinol Metab 10:391-396.
22. Hunyady L, Catt KJ. 2006. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953-970.
23. Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T, Yamakawa T. 1999. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 10:S57-S61.
24. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. 1993. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268:24539-24542.
25. Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH, Lee MH, Song HK, Cha DR, Kang SW, Han DS. 2006. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 36:377-388.
26. Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch AK. 1998. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol 18:2089-2099.
27. Landon EJ, Inagami T. 2005. Beyond the G protein: The saga of the type 2 angiotensin II receptor. Arterioscler Thromb Vasc Biol 25:15-16.
28. 2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase. Mol Endocrinol 2:499-511.
29. López F, Estève JP, Buscail L, Delesque N, Saint-Laurent N, Théveniau M, Nahmias C, Vaysse N, Susini C. 1997. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454.
30. Matsubara I, Shibasaki Y, Okigaki M, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T. 2001. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: Evidence from vascular-targeted transgenic mice of AT2 Receptor. Biochem Biophys Res Commun 282:1085-1091.
31. Miura S, Karnik SS. 2000. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 19:4026-4035.
32. Miura S, Karnik SS, Saku K. 2005. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 280:18327-18344.
33. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. 1993. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268:24539-24542.
34. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. 1991. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-236.
35. Neel BG, Gu H, Pao L. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293.
36. 2 receptor-interacting protein, ATIP. J Biol Chem 279:28989-28997.
37. Roskoski R. 2004. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324:1155-1164.
38. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. 1991. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351:230-233.
39. Somani AK, Bignon JS, Millsi GB, Siminovitch KA, Branch DR. 1997. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem 272:21113-21119.
40. Villarreal RS, Alvarez SE, Juri Ayub M, Ciuffo GM. 2006. Angiotensin II modulates Tyr-phosphorylation of IRS-4, an insulin receptor substrate, in rat liver membranes. Mol Cell Biochem 293:35-46.
41. Wu L, Iwai M, Li Z, Shiuchi T, Min L-J, Cui T-X, Li J-M, Okumura M, Nahmias C, Horiuchi M. 2004. Regulation of inhibitory protein-κB and monocyte chemoattractant protein-1 by angiotensin II Type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol 18:666-678.
42. Yin G, Yan C, Berk BC. 2003. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35:780-783.